1. Home
  2. INDP vs ORBS Comparison

INDP vs ORBS Comparison

Compare INDP & ORBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

SELL

Current Price

$3.07

Market Cap

438.4M

Sector

Health Care

ML Signal

SELL

Logo Eightco Holdings Inc.

ORBS

Eightco Holdings Inc.

HOLD

Current Price

$0.79

Market Cap

447.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
ORBS
Founded
2000
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.4M
447.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
INDP
ORBS
Price
$3.07
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
451.9K
★ 15.0M
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $31,820,779.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.57
52 Week High
$5.96
$7.17

Technical Indicators

Market Signals
Indicator
INDP
ORBS
Relative Strength Index (RSI) 55.54 39.59
Support Level $2.05 $0.78
Resistance Level $3.75 $1.22
Average True Range (ATR) 0.33 0.08
MACD 0.03 -0.03
Stochastic Oscillator 78.48 20.16

Price Performance

Historical Comparison
INDP
ORBS

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About ORBS Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Corrugated Packaging Business manufactured and sold custom packaging for a wide products and through packaging helps customers generate brand awareness and promote brand image. Generate the substantial majority of revenues from inventory financing and inventory management services.

Share on Social Networks: